Altimmune (ALT) Tax Rate (2012 - 2025)
Altimmune (ALT) reported Tax Rate of 3.36% for Q1 2025, up 304.68% on a QoQ basis from 0.83% in Q3 2022.
Altimmune (ALT) has 11 years of Tax Rate data on file, last reported at 3.36% in Q1 2025.
- Quarterly Tax Rate changed N/A year-over-year to 3.36% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 19.31% (changed N/A YoY) and the FY2025 annual result came in at 19.31%, changed N/A from the prior year.
- Tax Rate rose to 3.36% in Q1 2025 per ALT's latest filing, from 0.83% in the prior quarter.
- Across five years, Tax Rate topped out at 3.36% in Q1 2025 and bottomed at 0.83% in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7.07 |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.36 |
| Mar 31, 2025 | 3.36 |
| Sep 30, 2022 | 0.83 |
| Sep 30, 2022 | 0.83 |
| Dec 31, 2020 | 1.03 |
| Dec 31, 2020 | 1.03 |
| Sep 30, 2020 | 2.64 |
| Sep 30, 2020 | 2.64 |
| Jun 30, 2020 | 8.61 |
| Jun 30, 2020 | 8.61 |
| Mar 31, 2020 | 45.51 |
| Mar 31, 2020 | 45.51 |
| Sep 30, 2019 | 0.53 |
| Sep 30, 2019 | 0.53 |
| Dec 31, 2018 | -11.14 |
| Dec 31, 2018 | -11.14 |
| Sep 30, 2018 | 26.08 |
| Sep 30, 2018 | 26.08 |
| Jun 30, 2018 | 14.08 |
| Jun 30, 2018 | 14.08 |
| Mar 31, 2018 | 23.81 |
| Mar 31, 2018 | 23.81 |
| Dec 31, 2017 | 26.06 |
| Dec 31, 2017 | 26.06 |
| Sep 30, 2017 | 4.88 |
| Sep 30, 2017 | 4.88 |
| Jun 30, 2017 | 24.21 |
| Jun 30, 2017 | 24.21 |
| Mar 31, 2017 | 21.87 |
| Mar 31, 2017 | 21.87 |
| Dec 31, 2016 | 1.51 |
| Dec 31, 2016 | 1.51 |
| Sep 30, 2016 | -0.32 |
| Sep 30, 2016 | -0.32 |
| Jun 30, 2016 | -0.95 |
| Jun 30, 2016 | -0.95 |
| Mar 31, 2016 | -1.27 |
| Mar 31, 2016 | -1.27 |
| Dec 31, 2015 | -1.26 |
| Dec 31, 2015 | -1.26 |
| Sep 30, 2015 | -1.18 |
| Sep 30, 2015 | -1.18 |
| Jun 30, 2015 | -0.48 |
| Jun 30, 2015 | -0.48 |
| Mar 31, 2015 | 1.34 |
| Mar 31, 2015 | 1.34 |
| Dec 31, 2014 | -0.52 |
| Dec 31, 2014 | -0.52 |
| Sep 30, 2014 | -0.54 |
| Sep 30, 2014 | -0.54 |
| Jun 30, 2014 | 1.50 |
| Jun 30, 2014 | 1.50 |
| Mar 31, 2014 | -1.33 |
| Mar 31, 2014 | -1.33 |
| Dec 31, 2013 | -0.27 |
| Dec 31, 2013 | -0.27 |
| Sep 30, 2013 | -0.74 |
| Sep 30, 2013 | -0.74 |
| Jun 30, 2013 | -0.91 |
| Jun 30, 2013 | -0.91 |
| Mar 31, 2013 | -0.46 |
| Mar 31, 2013 | -0.46 |
| Dec 31, 2012 | -0.55 |
| Dec 31, 2012 | -0.55 |
| Sep 30, 2012 | -11.50 |
| Sep 30, 2012 | -11.50 |
| Jun 30, 2012 | -2.18 |
| Jun 30, 2012 | -2.18 |
| Mar 31, 2012 | -5.95 |
| Mar 31, 2012 | -5.95 |